- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 3 x CLR: CHOLESTEROL(Non-covalent)
- 21 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.5: 8 residues within 4Å:- Chain A: L.67, P.70, F.71, T.74, F.79, C.80
- Ligands: CLR.2, OLA.16
Ligand excluded by PLIPOLA.6: 5 residues within 4Å:- Chain A: L.199, L.203, Y.206, A.341, A.348
Ligand excluded by PLIPOLA.7: 1 residues within 4Å:- Ligands: CLR.3
Ligand excluded by PLIPOLA.8: 4 residues within 4Å:- Chain A: S.15, I.19, L.23, T.77
Ligand excluded by PLIPOLA.9: 1 residues within 4Å:- Chain A: V.17
Ligand excluded by PLIPOLA.10: 2 residues within 4Å:- Chain A: F.363
- Ligands: CLR.4
Ligand excluded by PLIPOLA.11: 10 residues within 4Å:- Chain A: Y.52, V.55, S.56, L.63, F.92, G.127, I.134, W.138, F.142
- Ligands: OLA.19
Ligand excluded by PLIPOLA.12: 3 residues within 4Å:- Chain A: V.17, W.373, Y.376
Ligand excluded by PLIPOLA.13: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOLA.14: 6 residues within 4Å:- Chain A: H.84, F.142, L.146, M.149
- Ligands: OLA.19, OLA.24
Ligand excluded by PLIPOLA.15: 4 residues within 4Å:- Chain A: S.16, T.20, L.23, A.24
Ligand excluded by PLIPOLA.16: 7 residues within 4Å:- Chain A: V.66, P.70, I.73, T.74, T.77, F.79
- Ligands: OLA.5
Ligand excluded by PLIPOLA.17: 3 residues within 4Å:- Chain A: P.371, W.373
- Ligands: CLR.3
Ligand excluded by PLIPOLA.18: 5 residues within 4Å:- Chain A: I.356, F.360, C.367
- Ligands: CLR.3, CLR.4
Ligand excluded by PLIPOLA.19: 7 residues within 4Å:- Chain A: I.134, A.135, W.138, F.142
- Ligands: OLA.11, OLA.14, OLA.24
Ligand excluded by PLIPOLA.20: 6 residues within 4Å:- Chain A: C.37, W.41, Y.52, V.55, A.59, I.62
Ligand excluded by PLIPOLA.21: 8 residues within 4Å:- Chain A: F.53, F.102, A.106, I.109, D.110, I.113, I.133, C.137
Ligand excluded by PLIPOLA.22: 1 residues within 4Å:- Chain A: W.41
Ligand excluded by PLIPOLA.23: 3 residues within 4Å:- Chain A: L.28, V.387, F.391
Ligand excluded by PLIPOLA.24: 5 residues within 4Å:- Chain A: A.143, M.149, L.150
- Ligands: OLA.14, OLA.19
Ligand excluded by PLIPOLA.25: 2 residues within 4Å:- Chain A: Y.188, F.192
Ligand excluded by PLIP- 1 x 01: 4-(furan-2-yl)-6-(6-imidazol-1-ylpyridin-2-yl)-1,3,5-triazin-2-amine
01.26: 13 residues within 4Å:- Chain A: A.72, S.76, L.94, F.177, E.178, M.186, W.351, L.354, H.355, N.358, M.375, Y.376, I.379
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:A.72, A:L.94, A:F.177, A:W.351, A:L.354
- Hydrogen bonds: A:N.358, A:N.358, A:N.358
- Salt bridges: A:E.178
- pi-Stacking: A:F.177
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morgan, T. et al., Identification of nanomolar adenosine A2A receptor ligands using reinforcement learning and structure-based drug design. To Be Published
- Release Date
- 2025-06-18
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 3 x CLR: CHOLESTEROL(Non-covalent)
- 21 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 1 x 01: 4-(furan-2-yl)-6-(6-imidazol-1-ylpyridin-2-yl)-1,3,5-triazin-2-amine
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morgan, T. et al., Identification of nanomolar adenosine A2A receptor ligands using reinforcement learning and structure-based drug design. To Be Published
- Release Date
- 2025-06-18
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.